193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC)

2012 ◽  
Vol 48 ◽  
pp. S96
Author(s):  
C. Saura ◽  
H. Burris ◽  
C.L. Arteaga ◽  
I. Mayer ◽  
C. Germa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Pi3k Inhibitor ◽  
Class I

scholarly journals A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer

2018 ◽  
Vol 18 (4) ◽  
pp. 289-297 ◽  
Author(s):  
Autumn J. McRee ◽  
Paul K. Marcom ◽  
Dominic T. Moore ◽  
William C. Zamboni ◽  
Zachary A. Kornblum ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Metastatic Breast ◽  
Pi3k Inhibitor

Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 1018-1018 ◽  
Author(s):  
Priyanka Sharma ◽  
Vandana Gupta Abramson ◽  
Anne O'Dea ◽  
Harsh B Pathak ◽  
Ziyan Y. Pessetto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Pi3k Inhibitor

scholarly journals Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer

2021 ◽  
pp. clincanres.4879.2020
Author(s):  
Priyanka Sharma ◽  
Vandana G Abramson ◽  
Anne P O'Dea ◽  
Lauren Nye ◽  
Ingrid A. Mayer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Pi3k Inhibitor

Phase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation

2001 ◽  
Vol 19 (5) ◽  
pp. 459-466 ◽  
Author(s):  
Nuhad K. Ibrahim ◽  
Vicente Valero ◽  
Zia Rahman ◽  
Richard L. Theriault ◽  
Ronald S. Walters ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Continuous Infusion ◽  
Dose Escalation ◽  
Metastatic Breast

scholarly journals A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

2002 ◽  
Vol 87 (1) ◽  
pp. 15-20 ◽  
Author(s):  
K J O'Byrne ◽  
A L Thomas ◽  
R A Sharma ◽  
M DeCatris ◽  
F Shields ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Liposomal Daunorubicin ◽  
Dose Escalating

scholarly journals A Phase I Study of Pemetrexed (ALIMTA) and Cyclophosphamide in Patients with Locally Advanced or Metastatic Breast Cancer

2006 ◽  
Vol 12 (23) ◽  
pp. 7071-7078 ◽  
Author(s):  
Christian Dittrich ◽  
Lubos Petruzelka ◽  
Pavel Vodvarka ◽  
Margit Gneist ◽  
Filip Janku ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Locally Advanced ◽  
Metastatic Breast
Sign in / Sign up

Export Citation Format

Share Document